AI Method Developed for Identifying Disease Biomarkers with High Accuracy
Researchers are developing a deep learning network capable of detecting disease biomarkers with a much higher degree of accuracy.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Cancer, Cardiovascular, Computing Systems, Covid 19 |
Researchers are developing a deep learning network capable of detecting disease biomarkers with a much higher degree of accuracy.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Flu & Respiratory Infections, Immunoassay Reagents & test Kits |
The Aptima SARS-CoV-2/Flu Assay from Hologic tests simultaneously for SARS-CoV-2, influenza A, and influenza B on the Panther molecular diagnostics system.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Emerging & Zoonotic Diseases |
According to new research, contaminated water has been the most common driver of large-scale zoonotic infectious disease outbreaks.
Read MorePosted by Chris Wolski | Oct 28, 2021 | Covid 19, POC Rapid Assays |
Dotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.
Read More